Logo Geneseeq
  • Services
    • Genomic Testing
      • Companion Diagnostic Test
      • Laboratory Developed Tests (LDT)
        • Solid Tumors
        • Hematologic Malignancies
        • Hereditary Cancers
        • Minimal Residual Disease
    • Research Services
      • Platforms
      • DNA Sequencing
      • RNA Sequencing
      • Other Services
  • Technology
    • Our Technology
    • Publications
  • Partnerships
  • About Us
    • What is Precision Oncology?
    • Our Company
    • Our Team
    • Certificates & Accreditation
  • News
  • Join Us
  • Contact Us
  • Ch|中文
  • Search

Geneseeq

June 13, 2022

Geneseeq Multicancer Early Detection Study Yields Promising Results


0 Comments3 Minutes

May 31, 2022

Geneseeq at ASCO 2022


0 Comments7 Minutes

May 19, 2022

Geneseeq collaborates on another minimal residual disease study in chemoradiotherapy-treated inoperable localized non-small cell lung cancer patients.


0 Comments3 Minutes

April 5, 2022

Geneseeq Presents 9 Posters at AACR 2022


0 Comments12 Minutes

January 4, 2022

Geneseeq’s cancer early detection study series DECIPHER yield another publication in HEPATOLOGY to explore the performance of cfDNA fragmentomics in liver cancer


0 Comments3 Minutes

November 22, 2021

Geneseeq announces new publication utilizing ultradeep sequencing technology Automated TTriple Groom sequencing (ATG-seq) to monitor minimal residual disease in postoperative non-small cell lung cancer


0 Comments3 Minutes

November 11, 2021

Geneseeq Forms Lung Cancer Strategic Partnerships with Takeda and AstraZeneca on the Same Day


0 Comments1 Minutes

November 8, 2021

Geneseeq collaborates on research identifying predictive biomarkers for guiding personalized adjuvant treatment in resected EGFR-positive non-small cell lung cancer


0 Comments4 Minutes

October 27, 2021

Geneseeq Study Shows High Performance Results in Colorectal Cancer Early Detection


0 Comments4 Minutes

October 13, 2021

Geneseeq and Zai Lab Announce Strategic Collaboration to Advance Cancer Drug R&D


0 Comments2 Minutes

  • 1
  • 2
  • 3
Logo Geneseeq

1-647-255-1076
1-800-362-0325
info.toronto@geneseeq.com

Quick Links
  • Services
  • Technology
  • News
  • About Us
Connect
  • Partnerships
  • Join us
  • Contact us
Privacy
  • Privacy Policy
  • Terms of Use
Headquarters

101 College Street
Suite 200, MaRS Centre
South Tower
Toronto, Ontario, M5G 1L7
Canada

© 2022 Geneseeq Technology Inc. | A Precision Oncology Company. All rights reserved

Privacy Preference Center

Privacy Preferences